ODONATE THERAPEUTICS, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits (form 8-K)

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or
Standard; Transfer of Listing

On January 6, 2022, Odonate Therapeutics, Inc. received written
notice from The Nasdaq... | January 7, 2022

Related Keywords

,Exchange Commission ,Odonate Therapeutics Inc ,Nasdaq Stock Market ,Nasdaq ,Continued Listing Rule ,Listing Rule ,Nasdaq Stock ,Page Interactive Data File ,Edgar Online ,Odonate Therapeutics ,Nc Stock Exchange ,News ,Information ,Press Release ,Item ,Notice ,F ,Elisting ,Dr ,Failure ,O ,Asatisfy ,Ontinued ,Listing ,Mule ,Transfer ,January ,Donate ,Eceived ,Rom ,He Odt Us6760791060 ,